$NUVB 4 SEC Filings

Filed On	Filing
21 Aug 2026	Form 4: Hattersley Gary, CHIEF SCIENTIFIC OFFICER Received 100,000 shares by exercise or conversion ($187K) · Sold 100,000 shares ($709K)
17 Jul 2026	Form 4: Sauvage Philippe, Chief Financial Officer Received 40,000 shares by exercise or conversion ($86.8K)
24 Jun 2026	Form 4: Markel Stacy, CHIEF PEOPLE OFFICER Received 125,000 shares by exercise or conversion ($229K) · Sold 125,000 shares ($753K)
24 Jun 2026	Form 4: Wentworth Kerry, CHIEF REGULATORY OFFICER Received 63,000 shares by exercise or conversion ($185K) · Sold 63,000 shares ($379K)
24 Jun 2026	Form 4: Sauvage Philippe, Chief Financial Officer Received 47,668 shares by exercise or conversion ($103K) · Sold 47,668 shares ($286K)
11 Jun 2026	Form 4: Mashal Robert, Director Bought 25,000 shares ($118K)
26 May 2026	Form 4: Vernon W Anthony, Director Granted 123,397 Stock Option (Right to Buy)
26 May 2026	Form 4: Mashal Robert, Director Granted 123,397 Stock Option (Right to Buy)
26 May 2026	Form 4: Falberg Kathryn E, Director Granted 123,397 Stock Option (Right to Buy)
26 May 2026	Form 4: Blickenstaff Kim D, Director Granted 123,397 Stock Option (Right to Buy)
26 May 2026	Form 4: Bazemore Robert B, Director Granted 123,397 Stock Option (Right to Buy)
26 May 2026	Form 4: Cui Xiangmin, Director Granted 123,397 Stock Option (Right to Buy)
21 Apr 2026	Form 4: Wentworth Kerry, CHIEF REGULATORY OFFICER Received 36,750 shares by exercise or conversion ($108K) · Sold 36,750 shares ($184K)
21 Apr 2026	Form 4: Liu Dongfang, CHIEF MEDICAL OFFICER Received 50,000 shares by exercise or conversion ($97K) · Sold 50,000 shares ($251K)
08 Apr 2026	Form 4: Wentworth Kerry, CHIEF REGULATORY OFFICER Received 200,000 shares by exercise or conversion ($381K) · Sold 200,000 shares ($904K)
03 Mar 2026	Form 4: Liu Dongfang, CHIEF MEDICAL OFFICER Granted 748,130 Stock Option (Right to Buy)
03 Mar 2026	Form 4: Makunje Moses, SEE REMARKS Received 50,761 shares as a grant or award · Granted 224,439 Stock Option (Right to Buy)
03 Mar 2026	Form 4: Wentworth Kerry, CHIEF REGULATORY OFFICER Granted 748,130 Stock Option (Right to Buy)
03 Mar 2026	Form 4: Sjogren Colleen, Chief Commercial Officer Granted 748,130 Stock Option (Right to Buy)
03 Mar 2026	Form 4: Sauvage Philippe, Chief Financial Officer Granted 748,130 Stock Option (Right to Buy)

Comments